BridgeBio Pharma (BBIO) Receivables - Other (2019 - 2024)
BridgeBio Pharma (BBIO) reported Receivables - Other of $200000.0 for Q3 2024, down 94.12% on a YoY basis from $3.4 million in Q4 2023, and little changed sequentially from $200000.0 in Q2 2024.
BridgeBio Pharma (BBIO) Receivables - Other (2019 - 2024) Analysis & Trends
BridgeBio Pharma (BBIO) has 6 years of Receivables - Other data on file, last reported at $200000.0 in Q3 2024.
- For the quarter ending Q3 2024, Receivables - Other fell 94.12% year-over-year to $200000.0; the trailing twelve-month figure through Sep 2024 stood at $200000.0 (down 94.12% YoY), and the FY2023 full-year result was $900000.0, down 94.64% from the prior year.
- Receivables - Other held at $200000.0 in Q3 2024, from $200000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $100.4 million in Q1 2024 to a low of $200000.0 in Q2 2024.
- A 5-year average of $14.0 million and a median of $6.4 million in 2021 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other jumped 6956.28% in 2022 and sank 96.92% in 2024, its largest moves.
- Tracing BBIO's Receivables - Other over 5 years: stood at $8.0 million in 2020, then declined by 21.25% to $6.3 million in 2021, then surged by 166.67% to $16.8 million in 2022, then slumped by 94.64% to $900000.0 in 2023, then plunged by 77.78% to $200000.0 in 2024.
- Business Quant data shows BBIO's Receivables - Other at $200000.0 in Q3 2024, $200000.0 in Q2 2024, and $100.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 100.40 Mn |
| Mar 31, 2024 | 100.40 Mn |
| Dec 31, 2023 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 3.40 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Mar 31, 2023 | 10.40 Mn |
| Mar 31, 2023 | 10.40 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 32.60 Mn |
| Sep 30, 2022 | 32.60 Mn |
| Dec 31, 2021 | 6.30 Mn |
| Dec 31, 2021 | 6.30 Mn |